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Abstract
Mycoplasma pneumoniae is a causative agent of atypical pneumonia. The formation of hydrogen peroxide, a product of
glycerol metabolism, is essential for host cell cytotoxicity. Phosphatidylcholine is the major carbon source available on lung
epithelia, and its utilization requires the cleavage of deacylated phospholipids to glycerol-3-phosphate and choline. M.
pneumoniae possesses two potential glycerophosphodiesterases, MPN420 (GlpQ) and MPN566. In this work, the function of
these proteins was analyzed by biochemical, genetic, and physiological studies. The results indicate that only GlpQ is an
active glycerophosphodiesterase. MPN566 has no enzymatic activity as glycerophosphodiesterase and the inactivation of
the gene did not result in any detectable phenotype. Inactivation of the glpQ gene resulted in reduced growth in medium
with glucose as the carbon source, in loss of hydrogen peroxide production when phosphatidylcholine was present, and in
a complete loss of cytotoxicity towards HeLa cells. All these phenotypes were reverted upon complementation of the
mutant. Moreover, the glpQ mutant strain exhibited a reduced gliding velocity. A comparison of the proteomes of the wild
type strain and the glpQ mutant revealed that this enzyme is also implicated in the control of gene expression. Several
proteins were present in higher or lower amounts in the mutant. This apparent regulation by GlpQ is exerted at the level of
transcription as determined by mRNA slot blot analyses. All genes subject to GlpQ-dependent control have a conserved
potential cis-acting element upstream of the coding region. This element overlaps the promoter in the case of the genes
that are repressed in a GlpQ-dependent manner and it is located upstream of the promoter for GlpQ-activated genes. We
may suggest that GlpQ acts as a trigger enzyme that measures the availability of its product glycerol-3-phosphate and uses
this information to differentially control gene expression.
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Introduction
Pathogenic bacteria have developed a large battery of enzymes
and mechanisms for extracting nutrients from their hosts, and the
requirement for nutrient acquisition can be regarded as one of the
driving forces for virulence [1–3]. In consequence, the metabolic
capabilities of a pathogen reflect its adaptation to a particular
niche in a particular host.
Mycoplasma pneumoniae is a causative agent of atypical pneumo-
nia, however implication of this bacterium in several additional
infections including encephalitis, aseptic meningitis, acute trans-
verses myelitis, stroke, and polyradiculopathy has been reported
[4–7]. These bacteria are members of the taxonomic class
Mollicutes that are characterized by an extreme reductive evolution
that results in the smallest genomes that allow independent life.
Moreover, the mollicutes have lost the cell wall and most
metabolic pathways, since they obtain the building blocks for
their cellular macromolecules from the host tissue. However, even
in these minimal pathogens, there is a close relation between
metabolism and virulence (for a review, see [8]). M. pneumoniae
thrives at the apical surface of lung epithelia. Thus, these bacteria
must have evolved to utilize the carbon sources present in this
niche. The pulmonary surfactant is composed of about 90%
phospholipids and 10% proteins [9]. This suggests that phospho-
lipids play a major role in the nutrition of M. pneumoniae.
Glycerophospholipids, the major building blocks of the cell
membrane in bacteria and eukaryotes, are degraded in several
steps. First, the fatty acids are cleaved from the phospholipids
resulting in the formation of glycerophosphodiesters. In these
molecules, the phosphate group of glycerol-3-phosphate is linked
to another compound, called the head group. In eukaryotes,
choline is by far the most abundant head group, and lecithin, the
choline-containing phospholipid accounts for about 80% of all
phospholipids in human lung cells [9]. In the second step, the
choline head group is cleaved due to the activity of a glyceropho-
sphodiesterase resulting in the formation of glycerol-3-phosphate
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phosphate (see Figure 1). In M. pneumoniae, the latter reaction is
catalyzed by the glycerol-3-phosphate oxidase GlpD [10]. GlpD
transfers the electrons to water resulting in the formation of
hydrogen peroxide, the major virulence factor of M. pneumoniae
[11]. In consequence, the virulence of M. pneumoniae glpD mutant
cells is severely attenuated [10].
While the metabolism of glycerol has been well studied in M.
pneumoniae and other mollicutes such as M. mycoides [10,12,13], only
little is known about the glycerophosphodiesterases required for
lipid utilization. Many bacteria encode multiple glyceropho-
sphodiesterases. In E. coli, both enzymes are enzymatically active
in lipid degradation; however, they are differentially regulated,
with GlpQ and UgpQ being induced in the presence of glycerol-3-
phosphate and under conditions of phosphate starvation, respec-
tively [14,15]. In B. subtilis, out of three putative glyceropho-
sphodiesterases, only GlpQ has been studied. The corresponding
gene is under dual control and its expression is induced when
phosphate becomes limiting and glycerol is available [16,17].
Moreover, glpQ expression is repressed if more favourable carbon
sources such as glucose are present [18]. In Haemophilus influenzae,
another bacterium thriving in the respiratory tract, the glycer-
ophosphodiesterase is involved in pathogenicity. The enzyme
generates choline, which in turn is used for the biosynthesis of the
bacterial lipopolysaccharide layer - a major virulence determinant
of Gram-negative bacteria [19,20]. Similarly, glycerophosphodies-
terase activity is implicated in virulence of different Borrelia species.
The enzyme is only present in the relapsing fever group and may
help the bacteria to reach a higher cell density in the blood of the
host as compared to Lyme disease spirochaetes [21].
In many bacteria, central enzymes of metabolism do not only
fulfil their catalytic function, but in addition, they are also involved
in signal transduction. In this way, the information on the
availability of important metabolites can be directly determined by
the enzyme in charge of their conversion, and this information is
then often transferred to the transcription machinery. Collectively,
such enzymes have been termed trigger enzymes [22]. They can
control gene expression by directly acting as DNA- or RNA-
binding transcription factors as the E. coli proline dehydrogenase
and the aconitase or by controlling the activity of transcription
factors by covalent modification or a regulatory protein-protein
interaction as observed for several sugar permeases of the bacterial
phosphotransferase system and the B. subtilis glutamate dehydro-
genase, respectively [23–26].
In this work, we have analyzed the role of the two potential
glycerophosphodiesterases encoded in the genome of M. pneumo-
niae. Biochemical and physiological studies demonstrate that one of
the two proteins, GlpQ, is a functional glycerophosphodiesterase.
GlpQ is essential for hydrogen peroxide formation in the presence
of deacylated phospholipids as the carbon source and, in
consequence, for cytotoxicity. Moreover, GlpQ may act as a
trigger enzyme by controlling the expression of a set of genes
encoding lipoproteins, the glycerol facilitator, and a metal ion
ABC transporter.
Results
Identification of M. pneumoniae genes encoding
potential glycerophosphodiesterases
Since phospholipids are the most abundant potential carbon
sources for M. pneumoniae living at lung epithelial surfaces, we
considered the possibility that these bacteria synthesize enzymes
that cleave the polar head groups from the glycerophosphodiesters
to produce glycerol-3-phosphate that can be utilized by the
enzymes of glycerol metabolism [10] (Figure 1). Two genes that
potentially encode such enzymes are present in the genome of M.
pneumoniae, i.e. mpn420 (renamed to glpQ) and mpn566.A n
alignment of the corresponding proteins to glycerophosphodies-
terases from other bacteria is shown in the supporting information
(Figure S1).
Enzymatic activities of the potential
glycerophosphodiesterases
In order to assess the biochemical properties and physiological
relevance of the putative glycerophosphodiesterases, their corre-
sponding genes, glpQ and mpn566, were cloned into the expression
vector pGP172, thus allowing a fusion of the proteins to an N-
terminal Strep-tag facilitating purification. The recombinant
proteins were purified and the activities were first determined
using glycerophosphocholine (GPC) as the substrate and a set of
divalent cations. As shown in Figure 2, purified GlpQ was active
against GPC, and the activity was highest in the presence of
magnesium ions (10 mM). Manganese and zinc ions did also
support activity, although to a lesser extent (Figure 2). In contrast,
the enzyme was inactive in the presence of calcium and cobalt ions
(data not shown). The activity assay with purified MPN566
revealed no activity with GPC, irrespective of the cation present in
the assay (data not shown). We did also test the activity of both
proteins with glycerophosphoethanolamine and glycerophospho-
glycerol. However, neither protein was active with any of these
substrates. Thus, our data demonstrate that GlpQ is active as a
glycerophosphodiesterase, whereas MPN566 does not exhibit such
an activity.
The two proteins GlpQ and MPN566 share ,58% identical
residues. Thus, it seems surprising that MPN566 was inactive in
the enzymatic assay. However, several residues that are known to
be important for the activity of glycerophosphodiesterases are
conserved in GlpQ but not in MPN566 (Figure S1). These
residues include Trp-36 and Glu-38 as well as the conserved HD
motif (Asn-51 and Leu-52 in MPN566) and Phe-110. Interestingly,
a similar arrangement with two GlpQ-like proteins is also observed
Author Summary
Mycoplasma pneumoniae serves as a model organism for
bacteria with very small genomes that are nonetheless
independently viable. These bacteria infect the human
lung and cause an atypical pneumonia. The major
virulence determinant of M. pneumoniae is hydrogen
peroxide that is generated during the utilization of
glycerol-3-phosphate, which might be derived from free
glycerol or from the degradation of phospholipids. Indeed,
lecithin is the by far most abundant carbon source on lung
epithelia. In this study, we made use of the recent
availability of methods to isolate mutants of M. pneumo-
niae and characterized the enzyme that generates
glycerol-3-phosphate from deacylated lecithin (glycero-
phosphocholine). This enzyme, called GlpQ, is essential for
the formation of hydrogen peroxide when the bacteria are
incubated with glycerophosphocholine. Moreover, M.
pneumoniae is unable to cause any detectable damage
to the host cells in the absence of GlpQ. This underlines
the important role of phospholipid metabolism for the
virulence of M. pneumoniae. We observed that GlpQ in
addition to its enzymatic activity is also involved in the
control of expression of several genes, among them the
glycerol transporter. Thus, GlpQ is central to the normal
physiology and to pathogenicity of the minimal pathogen
M. pneumoniae.
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conserved residues characteristic for glycerophosphodiesterases,
whereas the second protein has similar deviations from the
consensus as MPN566 (Figure S1). In order to test whether a
restoration of the conserved residues would also convert MPN566
to a biologically active glycerophosphodiesterase, we replaced the
five amino acids that differ from the consensus by those residues
present in GlpQ. The resulting mutant allele was cloned into
pGP172, and purification attempted. Unfortunately, this protein
was highly unstable and purification was impossible.
Construction of glpQ and mpn566 mutants
The analysis of mutants is one of the most powerful tools for
studying gene functions and bacterial physiology. The isolation of
desired M. pneumoniae mutants became possible only recently by the
introduction of the ‘‘Haystack mutagenesis’’ [27]. To get more
insights into the physiological role of the glycerophosphodies-
terases GlpQ and its paralog MPN566, we attempted to isolate
mutants affected in the corresponding genes.
The strategy of ‘‘Haystack mutagenesis’’ is based on an ordered
collection of pooled random transposon insertion mutants that can
be screened for junctions between the transposon and the gene of
interest due to transposon insertion. The 64 pools were used in a
PCR to detect junctions between the glpQ or mpn566 genes and the
mini-transposon using the oligonucleotides SS35 and SS40 (for the
respective genes) and SH30 (for the mini-transposon) [28]
(Figure 3). Positive signals were obtained for both genes. From
pools that gave a positive signal, colony PCR with the 50
individual mutants resulted in the identification of the desired glpQ
and mpn566 mutants. The presence of the transposon insertion in
both genes was verified by Southern blot analysis (Figure 3). To
test whether these strains contained only unique transposon
Figure 1. Schematic illustration of the machinery for uptake and conversion of carbohydrates leading to the formation of glycerol-
3-phosphate in M. pneumoniae. UgpC (MPN134), UgpA (MPN135), and UgpE (MPN136) form a putative ABC transport system for glycerol-3-
phosphate, whereas GlpF (MPN043) is the glycerol uptake facilitator. The glycerol kinase GlpK (MPN050) and the glycerol-3-phosphate oxidase GlpD
(MPN051) metabolize glycerol to the glycolytic intermediate dihydroxyacetone phosphate. Hydrogen peroxide formation by GlpD is crucial for the
cytotoxic effects of M. pneumoniae. GlpQ (MPN420) and MPN566 encode two paralogous glycerophosphodiesterases that may be able to metabolize
glycerophosphocholine to glycerol-3-phosphate and choline. The uptake system for glycerophosphocholine is so far unknown. Proteins highlighted
in grey seem not to fulfill the predicted function (this work). CM, cell membrane; DHAP, dihydroxyacetone phosphate; G3P, glycerol-3-phosphate;
GPC, glycerophosphocholine; Gly, glycerol; Cho, choline.
doi:10.1371/journal.ppat.1002263.g001
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the aac-aphD resistance gene present on the mini-transposon. As
shown in Figure 3, only one band hybridizing with this probe was
detected in each strain, moreover, this fragment had the same size
as the AgeIo rPstI/SacI fragment hybridizing to the glpQ and
mpn566 probe, respectively (Figure 3). The isolated glpQ and
mpn566 mutant strains were designated GPM81 and GPM82. The
position of the transposon insertion in the two genes was
determined by DNA sequencing. The glpQ gene was disrupted
between nucleotides 517 and 518, resulting in a truncated protein
of 172 amino acids with one additional amino acid and the
following stop codon encoded by the inserted mini-transposon.
The disruption of the mpn566 gene was located between
nucleotides 157 and 158, resulting in a truncated protein of 52
amino acids with one additional amino acid and the following stop
codon.
Contributions of GlpQ and MPN566 to growth and
motility
First, we compared the ability of the wild type strain and the two
mutant strains to utilize glucose and glycerol as the single carbon
sources (Figure 4). As an additional control, we used the glpD
mutant strain GPM52. This strain is defective in glycerol-3-
phosphate oxidase and therefore unable to utilize glycerol as the
only carbon source [10]. As shown in Figure 4A, the wild type and
the glpD and mpn566 mutant strains grew well with glucose. In
contrast, the glpQ mutant GPM81 grew more slowly and did not
reach the final biomass as compared to the other strains. As
reported previously, the wild type strain exhibited very slow
growth with glycerol as the only carbon source [29]. In this
respect, the glpQ and mpn566 mutants were indistinguishable from
the wild type. As reported previously, the glpD mutant strain did
not grow at all in glycerol-containing medium [10]. In conclusion,
the active glycerophosphodiesterase GlpQ is required for maximal
growth in the presence of glucose, whereas its absence does not
interfere with the slow growth in the presence of glycerol.
Since the disruption of glpQ affected the growth properties of the
bacteria, we wondered whether this might reflect changes in cell
morphology and in the movement of the bacteria. The
morphology of the wild type and mutant bacteria was analyzed
by scanning electron microscopy, and no differences were detected
(Figure S2). An analysis of the gliding velocities of the three strains
revealed that the wild type strain glided with a velocity of
0.3260.09 mm/s, whereas the glpQ and mpn566 mutants exhibited
velocities of 0.260.08 mm/s and 0.360.1 mm/s, respectively
(Videos S1, S2, and S3). Thus, the active glycerophosphodiester-
ase GlpQ is required for full gliding velocity of the bacteria.
Implication of GlpQ and MPN566 in hydrogen peroxide
production and cytotoxicity
The utilization of glycerol or glycerophosphodiesters results in
the generation of hydrogen peroxide, the major cytotoxic product
of M. pneumoniae. We asked therefore whether the glpQ and mpn566
disruptions would affect hydrogen peroxide formation and if so,
Figure 2. Effect of divalent cations on GlpQ activity. GlpQ activity was measured in the presence of 0.5 mM glycerophosphocholine and
various concentrations of divalent cations. Error bars indicate the standard deviation (based on three independent experiments).
doi:10.1371/journal.ppat.1002263.g002
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was assayed in M. pneumoniae cultures that contained glucose,
glycerol, GPC, glycerol-3-phosphate or no carbon source. In the
absence of an added carbon source, neither the wild type strain
nor the mutants formed substantial amounts of hydrogen peroxide
(Figure 5). It is interesting to note that the wild type and the
mpn566 mutant formed some hydrogen peroxide even in the
absence of any added carbon source. This might result from the
presence of low concentrations of phospholipids in the medium.
Similarly, essentially no hydrogen peroxide was produced in the
presence of glucose. If glycerol was available, maximal hydrogen
peroxide formation (9.5 mg/l) was observed in the wild type strain.
In the glpD mutant that served as a control, no hydrogen peroxide
was formed. This is in good agreement with previous reports on
the increase of hydrogen peroxide generation in the presence of
glycerol and its dependence on a functional glycerol-3-phosphate
oxidase [10]. The hydrogen peroxide production in the glpQ and
mpn566 mutants was similar to that observed in the wild type
strain. This result reflects that the metabolite glycerol is
downstream from the glycerophosphodiesterase activity. In the
presence of GPC, the wild type strain produced similar amounts of
hydrogen peroxide (9 mg/l) as in the presence of glycerol. In
contrast, no hydrogen peroxide formation was detected for the
glpQ mutant GPM81, whereas the disruption of mpn566 did not
have any effect on the production of hydrogen peroxide (Figure 5).
This result is in good agreement with the enzymatic activities of
the two proteins: GlpQ is the only active glycerophosphodiesterase
in M. pneumoniae, and no glycerol-3-phosphate, the substrate of
GlpD, can be formed in its absence, whereas MPN566 is
dispensable for the utilization of GPC. We also tested the ability
of the M. pneumoniae strains to form hydrogen peroxide in the
presence of glycerophosphoethanolamine and glycerophosphogly-
cerol. These compounds did not stimulate hydrogen peroxide in
any of the strains tested (data not shown). This is in excellent
agreement with the result of the enzyme assay that suggested that
neither GlpQ nor MPN566 is able to degrade these substances.
Finally, we tested whether hydrogen peroxide was formed in the
presence of glycerol-3-phosphate. As shown in Figure 5,n o
Figure 3. Isolation of M. pneumoniae glycerophosphodiesterases transposon insertion mutants. (A, C) Schematic representation of the
genomic region surrounding the glpQ and mpn566 gene (both designated as glycerophosphodiesterases) in M. pneumoniae and site of the
transposon insertion in the knockout strains GPM81 and GPM82, respectively. The annealing sites of oligonucleotides used for the determination of
the transposon insertion site are indicated by small arrows. Probes A and B hybridizing to internal fragments of the glycerophosphodiesterases and
the aac-ahpD genes are depicted as dotted lines. (B, D) Southern blot analysis to confirm the single insertion of the mini-transposon into the glpQ and
mpn566 gene of the strains GPM81 and GPM82, respectively. Chromosomal DNAs of the wild type and both glycerophosphodiesterase mutants were
digested as indicated. Blots were hybridized with the respective glycerophosphodiesterase-specific probe (left) and a probe hybridizing to the aac-
ahpD gene of the mini-transposon (right).
doi:10.1371/journal.ppat.1002263.g003
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the strains tested. This suggests that the uptake of glycerol-3-
phosphate is rather inefficient.
To assess the cytotoxicity of the different M. pneumoniae strains,
we infected confluently grown HeLa cell cultures with M.
pneumoniae cells (multiplicity of infection: 2). The cytotoxicity of
Figure 4. Growth of M. pneumoniae in modified Hayflick medium containing different carbon sources. One hundred milliliters of
medium were inoculated with 5 mg of the relevant M. pneumoniae cells and incubated for up to six days at 37uC in 150-cm
2 cell culture flasks. The
following strains were used: wild type (wt), glpQ::Tn, mpn566::Tn, and glpD::Tn, glpQ::Tn + glpQ (complemented mutant) and glpQ::Tn + cv (control
strain carrying the empty vector used for complementation). Glucose (A) and glycerol (B) were added to a final concentration of 1% (wt/vol). Attached
cells were collected by scraping and growth was monitored by determination of the wet weight of the cell pellets. All measurements were done three
times. Results are from a representative experiment.
doi:10.1371/journal.ppat.1002263.g004
Figure 5. Examination of M. pneumoniae hydrogen peroxide release. Hydrogen peroxide production of M. pneumoniae mutant strains was
measured in the presence of different carbon sources (100 mM) after 2 h. The following strains were used: wild type (wt), glpQ::Tn, mpn566::Tn, and
glpD::Tn, glpQ::Tn + glpQ (complemented mutant) and glpQ::Tn + cv (control strain carrying the empty vector used for complementation). Error bars
indicate standard deviation (based on three independent experiments). G3P, glycerol-3-phosphate; GPC, glycerophosphocholine; Glc, glucose; Gly,
glycerol; w/o, without addition of any carbon source.
doi:10.1371/journal.ppat.1002263.g005
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pneumoniae GPM52 that is affected in glpD. As shown in Figure 6,
the HeLa cells had undergone nearly complete lysis after four days
upon infection with wild type M. pneumoniae (cytotoxicity of 89%).
As observed previously, the glpD mutant GPM52 has a reduced
cytotoxicity (51%) resulting in a large portion of viable cells after
infection [10]. For the glpQ mutant GPM81, nearly all HeLa cells
had survived the infection suggesting that GlpQ is essential for
cytotoxicity. In contrast, cytotoxicity induced by the mpn566
mutant strain GPM82 was equivalent to that of the wild type strain
(Figure 6). These data clearly demonstrate that the active
glycerophosphodiesterase GlpQ is required for host cell damage,
whereas MPN566 is not. Moreover, they support the assumption
that hydrogen peroxide formation is the major factor that
contributes to host cell damage.
Complementation of the glpQ mutation
In order to exclude the possibility that the phenotypes observed
with the glpQ mutant are due to a polar effect on the downstream
alaS gene, we compared the alaS transcript levels in the wild type
strain and the glpQ mutant. We observed fourfold increased
amounts of alaS mRNA levels in the glpQ mutant, most likely due
to the presence of a strong promoter in the transposon (data not
shown). The expression of the alaS gene in the glpQ mutant
strongly suggests that the observed phenotypes are the result of the
glpQ disruption rather than of a polar effect. However, to provide
unequivocal evidence for the implication of GlpQ in the growth
phenotype as well as in hydrogen peroxide production and
cytotoxicity, we performed a complementation assay. For this
purpose, the M. pneumoniae glpQ gene with its own promoter was
cloned into the integrative vector pMTnTetM438 and introduced
into the chromosome of the glpQ mutant GPM81 (for details, see
‘‘Materials and Methods’’). The resulting complementation strain
GPM92 and the isogenic glpQ mutant GPM93 carrying the empty
vector integrated into the chromosome were analysed for growth
in the presence of glucose and glycerol, for hydrogen peroxide
formation and for cytotoxicity. As shown in Figure 4A, the
complemented mutant grew in the presence of glucose as the wild
type strain. In contrast, the control strain carrying the empty
vector grew slowly in the presence of glucose and was in this
respect indistinguishable from the original glpQ mutant. These
data clearly establish that the growth defect of the glpQ mutant in
Hayflick medium containing glucose is a specific result of the glpQ
inactivation. Similar results were observed for hydrogen peroxide
production. Ectopic expression of the glpQ gene in the mutant
strain restored the wild type phenotype, i.e. strong hydrogen
peroxide formation in the presence of GPC. Again, the empty
vector did not alter the phenotype of the glpQ mutant (see Figure 5).
Finally, we assessed the cytotoxicity of the complemented strain
towards HeLa cells. As one would expect from the restoration of
hydrogen peroxide production upon complementation, the
complemented mutant GPM92 was toxic for the HeLa cells,
whereas the mutant carrying the control vector was not (Figure 6).
In conclusion, ectopic expression of glpQ complemented all mutant
phenotypes thus demonstrating, that the active glycerophospho-
diesterase GlpQ is indeed essential for hydrogen peroxide
production in the presence of the major substrate glyceropho-
sphocholine and for cytotoxicity of M. pneumoniae.
Figure 6. Cytotoxicity of M. pneumoniae toward HeLa cell cultures. (A) Infection assay to verify cytotoxic effects of M. pneumoniae glpQ::Tn
and mpn566::Tn mutant strains. HeLa cells were infected with M. pneumoniae wild type (wt), glpQ::Tn, and mpn566::Tn mutant cells. As control served
two HeLa cell cultures: One without addition of any M. pneumoniae cells and another after infection with glpD::Tn mutant strain [10]. Moreover,
cytotoxicity of the complemented mutant (glpQ::Tn + glpQ) and of the mutant carrying the empty vector (glpQ::Tn + cv) was tested. After four days,
HeLa cell cultures were stained with crystal violet and photographed. All pictures are shown at the same magnification. Scale bar, 0.1 mm. (B)
Quantification of cytotoxicity caused by M. pneumoniae in HeLa cell cultures. HeLa cells were infected with different M. pneumoniae strains or left
uninfected (negative control). LDH release of HeLa cell cultures after 2 h of infection was used as an index of cytotoxicity. Cytotoxicity was calculated
as the percentage of total LDH release after complete cell lysis. Error bars indicate standard deviation (based on three independent experiments).
doi:10.1371/journal.ppat.1002263.g006
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As reported above, the glpQ mutant exhibits multiple pheno-
types related to motility, metabolism, and pathogenicity. We asked
therefore whether some of the effects are due to changes in the
proteome of the glpQ mutant GPM81. To answer this question, we
compared the total protein profiles of the wild type strain and the
glpQ and mpn566 mutants, GPM81 and GPM82, respectively, after
growth in glucose and glycerol. While the protein patterns in the
mpn566 mutant were indistinguishable from the wild type strain
under both conditions, several differences were noted for the glpQ
mutant.
To identify those proteins that exhibit altered accumulation in
the glpQ mutant, the total proteins of the wild type and the glpQ
mutant strains were identified by mass spectrometry. For the
protein extracts from glucose-grown cells, 532 different proteins
were identified. This corresponds to about 77% of the theoretical
proteome of M. pneumoniae. In the presence of glycerol, 473
proteins corresponding to 69% of the theoretical proteome were
identified. The differences in protein expression between glucose-
and glycerol-grown cells as well as proteins that could not be
detected at all are summarized in Tables S1 and S2. A detailed list
of the differences of the protein profiles between the wild type
strain and the glpQ mutant is presented in Tables S3 and S4.A s
expected, the GlpQ protein was detected in the protein extracts of
the wild type strain but not in those of the glpQ mutant strain. In
glucose-grown cells, 33 and 21 proteins were in elevated and
reduced amounts, respectively, in the glpQ mutant. The strongest
increase was observed for the glycerol facilitator GlpF and the
uncharacterized lipoprotein MPN162. A strongly reduced accu-
mulation was observed for the lipoprotein MPN506. In the
presence of glycerol, five induced and five repressed proteins were
detected (see Table S4). Five proteins were subject to a identical
regulation under both conditions (Table 1).
It has been shown before that changes at the proteome level
may result from altered gene expression or from changes in
protein stability [30,31]. Therefore, we studied the expression of
the genes corresponding to the most prominently regulated
proteins and of genes encoding potential regulators, transport
systems and potential pathogenicity factors. For this purpose, we
isolated RNA from cultures grown in modified Hayflick medium
supplemented with glucose and performed slot blot analyses
(Figures 7 and S3).
These studies demonstrated that the regulation of the glycerol
facilitator GlpF and the lipoproteins MPN162 and MPN506
occurs at the level of transcription (Table 1). Moreover, our results
confirmed the higher expression of glpF and mpn162 and the
repression of mpn506 in the glpQ mutant. For the other proteins
that were induced in the presence of glucose, with exception of
plsC and mpn566 (nearly two-fold higher transcript levels), similar
accumulation of the mRNAs compared to the protein amount was
observed (Table S3 and Figure S3). In contrast, for the proteins
that were present in reduced amounts in glucose-grown cells, no
changes of the corresponding mRNAs were observed for all
transport proteins. Interestingly, the lipoprotein MPN083 showed
a similar pattern at the level of transcription as the induced
proteins and the ribonucleoside-diphosphate reductase (encoded
by nrdFIE) was the only protein with reduced mRNA amounts,
however changes in transcript level were not significant (Table S3
and Figure S3).
Identification of a potential target site for GlpQ-
dependent regulation
The proteome and transcription analyses identified three genes
that are significantly regulated - either induced or repressed - in a
GlpQ-dependent manner. An inspection of the upstream region of
these genes revealed the presence of a common palindromic DNA
motif (Figure 8). To exclude the possibility that this motif is
randomly distributed in the genome of M. pneumoniae because of
the extremely AT-rich consensus sequence, we tested its presence
in the genome using the GLAM2SCAN algorithm [32]. In nine
cases (matching score cut-off $30), this potential motif was located
upstream of open reading frames, among them the three genes
mentioned above. Therefore, the expression of the remaining six
genes was tested by slot blot analysis, and for two of these genes,
cbiO and mpn284, a significant accumulation and reduction of the
mRNA, respectively, was observed (data not shown; Figure 7).
Interestingly, the corresponding proteins, a subunit of a putative
metal ion ABC transporter CbiO and the uncharacterized
lipoprotein MPN284 were found to be present in higher or lower
amounts in the glpQ mutant in glycerol-grown cell. Thus, there is a
very good agreement between the regulatory effect of GlpQ at the
proteome level, the regulation at the level of transcription, and the
presence of the cis-acting element.
Discussion
Two cytotoxicity factors are known in M. pneumoniae: The
formation of hydrogen peroxide and the CARDS toxin that
possesses ADP-ribosyltransferase activity [11,33]. This work
establishes that the glycerophosphodiesterase GlpQ of M.
pneumoniae is essential for cytotoxicity of these bacteria. This is in
excellent agreement with previous reports that carbon metabolism
is intimately linked to virulence in pathogenic bacteria, including
M. pneumoniae and other mollicutes [1,2,8]. The utilization of
glycerol and phospholipids plays a particularly important role in
the virulence of Mycoplasma species: Hydrogen peroxide, the major
Table 1. Proteins with GlpQ-dependent expression pattern.
Fold-change in the presence of glucose
a Fold-change in the presence of glycerol
a
Locus name Protein name Protein function Protein level Transcript level Protein level Transcript level
MPN043 GlpF Glycerol uptake facilitator 10.7961.06 5.6960.36 5.8360.76 3.3260.34
MPN162 - Uncharacterized lipoprotein 9.9660.97 5.2360.23 5.4160.83 2.8160.47
MPN284 - Uncharacterized lipoprotein ns 0.2560.05 0.3660.02 0.3560.04
MPN433 CbiO Metal ion ABC transporter ns 7.5660.39 5.6660.49 2.9260.24
MPN506 - Uncharacterized lipoprotein 0.1060.03 0.0760.05 0.1860.04 0.1660.02
aFold-change cut off $2.0 and #0.5, respectively (glpQ mutant strain vs. wild type). Abbreviation: ns, no significant difference.
For detailed information on proteome and transcript changes in the glpQ mutant GPM81, see Tables S3 and S4.
doi:10.1371/journal.ppat.1002263.t001
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product of glycerol metabolism, and both glpD and glpQ mutants
are severely affected in pathogenicity [10, this work]. In M.
mycoides, pathogenicity is associated with the presence of a highly
efficient ABC transporter for glycerol. Non-pathogenic strains of
M. mycoides rely on the less efficient glycerol facilitator for glycerol
uptake [34].
In M. pneumoniae, GlpQ is not only important for virulence but
also for growth in the commonly used medium in the laboratory,
i.e. Hayflick medium with glucose as the added carbon source (see
Figure 4A). This observation is in good agreement with a recent
analysis of the M. pneumoniae metabolism that suggested that
glycerol is essential for growth of M. pneumoniae [35]. Accordingly,
no difference between the wild type strain and the glpQ mutant was
observed during growth in the presence of glycerol (see Figure 4B).
Therefore, it is tempting to speculate that some glyceropho-
sphodiesters in the Hayflick medium support growth.
In addition to GlpQ, M. pneumoniae encodes a second paralogous
protein. However, as shown in this work, this protein does not
exhibit enzymatic activity nor does the inactivation of the
corresponding gene (mpn566) cause any detectable phenotype.
This lack of detectable activity of MPN566 is easily explained by
the lack of conservation of amino acid residues that are essential
for the activity as a glycerophosphodiesterase. Interestingly, a very
similar arrangement with two glpQ-like genes is also present in M.
genitalium and Mycoplasma alligatoris. Based on the conservation of
the catalytically important residues (see Figure S1), there is an
active and an inactive enzyme in M. genitalium, as observed here for
M. pneumoniae.I nM. alligatoris, both potential glycerophosphodies-
terases contain all the important amino acids suggesting that both
Figure 7. Transcription analysis of GlpQ-dependent genes in M. pneumoniae. Slot blots were performed with whole RNA extracts of
M. pneumoniae wild type (wt), glpQ::Tn, mpn566::Tn, and glpD::Tn (control) mutant strains grown in modified Hayflick medium containing either
glucose or glycerol as sole carbon source (1% [wt/vol]). A dilution series of RNA extracts was blotted onto a positively charged nylon membrane and
probed with a DIG-labeled riboprobe specific for an internal part of a particular open reading frame. Names of riboprobes are given next to each blot.
Signals obtained with 1 mg of RNA are shown. Yeast tRNA and M. pneumoniae chromosomal DNA served as controls. For detailed information on
differences of transcript levels see Table 1, S3, and S4.
doi:10.1371/journal.ppat.1002263.g007
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the possession of two active glycerophosphodiesterases is related to
the fact that M. alligatoris is the only mollicute that obligatorily
causes fatal infections [36]. In the syphilis spirochaete, Treponema
pallidum, one glpQ-like gene is present; however, the encoded
protein is not active as a glycerophosphodiesterase. Again, the
inactivity is most likely caused by the lack of conservation of
functionally important amino acids [37,38]. The presence of
inactive GlpQ-like proteins in several pathogens, including a
spirochaete and M. genitalium, the bacterium with the smallest
genome, suggests that these proteins have other functions that
have yet to be identified. Unfortunately, the experiments reported
in this study did not give any hints as to a putative function of
MPN566.
Many proteins have activities in addition to their primary
functions. On one hand, this allows gene duplication and
specialization to non-related functions of similar proteins. On
the other hand, a protein may acquire a second useful activity and
act as a so-called moonlighting protein [39]. The former is very
common and might apply to the putative functional specialization
of GlpQ and MPN566. In contrast, the latter phenomenon is true
for all trigger enzymes that measure the availability of their
respective metabolites and transduce this information to the
regulatory machinery of the cell. In mammals, a glyceropho-
sphodiesterase controls the development of skeletal muscles
independent from its enzymatic activity [40]. Our results suggest
that GlpQ might also have such a second activity. Indeed, the
expression of the glycerol facilitator GlpF, a lipoprotein, and the
ATP-binding subunit of a metal ion ABC transporter are strongly
overexpressed in the glpQ mutant, whereas two uncharacterized
lipoproteins are less expressed in the mutant. Interestingly, the
genes that appear to be repressed by GlpQ are more strongly
transcribed in the presence of glycerol as the carbon source (as
compared to glucose). In contrast, the two lipoprotein genes
mpn284 and mpn506 that require GlpQ for expression are only
weakly expressed in the presence of glycerol, but they are strongly
induced if glucose is used as the carbon source. These observations
might be explained as follows: In the presence of glucose, only little
glycerol or glycerol-3-phosphate (the product of the reaction
catalyzed by GlpQ) is present in the cell. Free GlpQ might then
directly bind DNA or trigger the DNA-binding activity of another,
yet unknown transcription factor, resulting in repression or
activation of the two sets of genes. In the presence of glycerol,
glycerol-3-phosphate would be formed due to the activity of
glycerol kinase, and this metabolite might then prevent GlpQ from
its regulatory activity. As a result, those genes that are subject to
Figure 8. Transcriptional organization of GlpQ-dependent genes in M. pneumoniae. (A) Nucleotide sequence of promoter regions of
M. pneumoniae glpF (mpn043), mpn162, cbiO (mpn433), mpn284, and mpn506 genes. Promoter sequences are numbered relative to the 5’ end.
Directions of the open reading frames (ORF) are indicated by dotted arrows and predicted ATG/TTG start codons are highlighted by bold type. The
respective -10 motifs are underlined. GlpQ-dependent cis-acting elements (palindromic DNA motifs) are indicated by grey shading. (B) Consensus
sequence of the GlpQ-dependent palindromic DNA motif in M. pneumoniae. The sequence logo was created using WebLogo v2.8.2 [50] based on all
five palindromic DNA motifs mentioned in A.
doi:10.1371/journal.ppat.1002263.g008
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expressed than in the presence of glucose, whereas the GlpQ-
activated genes (mpn284, mpn506) would be less expressed. Finally,
in the glpQ mutant, the former set of GlpQ-repressed genes is
highly constitutively expressed, and only a very low level of
transcription can be detected for the two GlpQ-dependent
lipoprotein genes. Since glycerol-3-phosphate is the product of
the glycerophosphodiesterase reaction, this metabolite is an
excellent candidate for detection by GlpQ. Moreover, the glpQ
gene is constitutively expressed and the GlpQ protein was detected
in M. pneumoniae cells irrespective of the carbon source used in
similar amounts in this study [41, this study]. Thus, GlpQ is
available in the cell under all conditions to cause regulation. In a
recent study on the phosphoproteome of M. pneumoniae, phos-
phorylation of GlpQ was observed [42]; however, no precise
phosphorylation site could be detected and predicted, respectively.
Therefore, the functional relevance of this modification remains
unknown so far.
As observed for several other transcription regulators and
trigger enzymes, GlpQ exerts both an activating and repressing
effect on gene expression. The location of the putative cis-acting
element correlates perfectly with the regulatory effect: Those genes
that seem to be repressed by GlpQ-dependent manner have this
element overlapping or in the very close vicinity of the -10 region
of the promoters. This element is the only conserved promoter
element in M. pneumoniae and it is sufficient for transcription
initiation [30,41,43]. Binding of GlpQ or of a transcription factor
that is controlled by GlpQ would prevent a productive interaction
with RNA polymerase and therefore cause transcription repres-
sion. On the other hand, the cis-acting elements that may be
involved in the regulation of the GlpQ-activated genes are located
upstream of the promoters. This is usually the case for binding sites
of transcription activators and fits perfect with the observed
regulation.
Our future work will focus on the elucidation of the
mechanism(s) by which GlpQ controls gene expression. Moreover,
we will address the functions of the lipoproteins that are subject to
glycerol- and GlpQ-dependent regulation.
Materials and Methods
Bacterial strains and growth conditions
The M. pneumoniae strains used in this study were M. pneumoniae
M129 (ATCC 29342) in the 32nd broth passage, and its isogenic
mutant derivatives GPM52 (glpD::mini-Tn, Gm
R) [10], GPM81
(glpQ::mini-Tn, Gm
R), and GPM82 (mpn566::mini-Tn, Gm
R). M.
pneumoniae was grown at 37uC in 150 cm
2 tissue culture flasks
containing 100 ml of modified Hayflick medium as described
previously [29]. Carbon sources were added to a final concentra-
tion of 1% (w/v). Growth curves were obtained by determining
the wet weight of M. pneumoniae cultures as described previously
[29]. Strains harboring transposon insertions were cultivated in the
presence of 80 mg/ml gentamicin and/or 2 mg/ml tetracycline as
required. Escherichia coli DH5a and BL21(DE3)/pLysS [44] were
used as host for cloning and recombinant protein expression,
respectively.
The sequences of the oligonucleotides used in this study are
listed in Table S5.
Construction of a glpQ complementation strain
To achieve complementation of the glpQ mutant, we construct-
ed strain GPM92 as follows: The M. pneumoniae glpQ gene including
its own promoter was amplified using the primer pair SS245/
SS267. The PCR product was digested with EcoRI and XhoI and
cloned between the EcoRI/SalI sites of the integrative plasmid
pMTnTetM438 [45]. The resulting plasmid, pGP695, was
introduced by electroporation into the genome of the M.
pneumoniae glpQ mutant GPM81. As a control, we transformed
GPM81 with the empty vector pMTnTetM438. The resulting
strain was M. pneumoniae GPM93. To exclude multiple insertions of
the integrative plasmids in the two constructed strains, we
performed Southern blot analyses with both mutants using a
probe specific for the tetracycline resistance gene. In both cases,
unique insertion events were detected.
M. pneumoniae chromosomal DNA was prepared as described
previously [28]. Finally, digests of chromosomal DNA were
separated using 1% agarose gels and transferred onto a positively
charged nylon membrane (Roche Diagnostics) [44] and probed
with Digoxigenin labeled riboprobes obtained by in vitro
transcription with T7 RNA polymerase (Roche Diagnostics) using
PCR-generated fragments as templates. Primer pairs for the
amplification of glpQ, mpn566, aac-ahpD, and tet gene fragments
were SS42/SS43, SS44/SS45, SH62/SH63, and SS272/SS273,
respectively (Table S5). The reverse primers contained a T7 RNA
polymerase recognition sequence. In vitro RNA labeling, hybrid-
isation and signal detection were carried out according to the
manufacturer’s instructions (DIG RNA labeling Kit and detection
chemicals; Roche Diagnostics).
Production and analysis of recombinant putative
glycerophosphodiesterases
The M. pneumoniae genes encoding proteins similar to glycer-
ophosphodiesterases (glpQ and mpn566) were amplified with
chromosomal DNA as the template and the primer pairs SS34/
SS35 and SS39/SS40, respectively. The PCR products were
digested with SacI and BamHI and cloned into the expression
vector pGP172 that allows the fusion of the target proteins to a
Strep-tag at their N-terminus [46]. The resulting plasmids were
pGP1018 and pGP1020. Since the glpQ gene contains three TGA
codons that are recognized as stop codons in E. coli, these codons
were replaced by TGG specifying tryptophan as in M. pneumoniae.
For this purpose we applied the multiple mutation reaction [47]
using the phosphorylated mutagenesis primers SS36, SS37, and
SS38 and the external primers SS34 and SS35. The PCR product
was digested and cloned into pGP172 as described above. The
resulting expression vector was pGP1019. The plasmids pGP1019
and pGP1020 allowed the purification of the putative M.
pneumoniae glycerophosphodiesterases (GlpQ and MPN566) carry-
ing an N-terminal Strep-tag.
A mutant variant of MPN566 was obtained by the multiple
mutation reaction using pGP1020 as the template and the
phosphorylated mutagenesis primers SS192, SS193, and SS194
and the external primers SS39 and SS40. The PCR product was
cloned into pGP172 as described above and the resulting plasmid
was pGP661.
The putative glycerophosphodiesterases were overexpressed in
E. coli BL21(DE3)/pLysS. Expression was induced by the addition
of IPTG (final concentration 1 mM) to exponentially growing
cultures (OD600 of 0.8). Cells were lysed using a french press
(20.000 p.s.i., 138,000 kPa, two passes, Spectronic Instruments,
UK). After lysis the crude extracts were centrifuged at 15,000 g for
60 min. The crude extract was passed over a Streptactin column
(IBA, Go ¨ttingen, Germany). The recombinant proteins were
eluted with desthiobiotin (IBA, final concentration 2.5 mM).
After elution the fractions were tested for the desired protein
using 12% SDS-PAGE. Only fractions that contained the desired
protein in apparent homogeneity (content of the specific protein
.95%) were used for further experiments. The relevant fractions
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determined according to the method of Bradford using the Bio-
Rad dye-binding assay where Bovine serum albumin served as the
standard.
Glycerophosphodiesterase activity was measured in a coupled
spectrophotometric assay as described previously [48]. The
enzyme assay is based on the formation of glycerol-3-phosphate
and the subsequent oxidation by the glycerol-3-phosphate
dehydrogenase and the formation of NADH. Briefly, 5 mgo f
glycerophosphodiesterase were incubated with 20 U of rabbit
muscle glycerol-3-phosphate dehydrogenase (Sigma) in a 0.9 M
glycine-hydrazine buffer containing 0.5 mM glycerophosphodie-
ster and 0.5 mM NAD
+ in a volume of 1 ml. Divalent cations
were added as indicated. NADH formation was determined
photospectrometrically at 340 nm.
Determination of in vivo hydrogen peroxide production
The hydrogen peroxide production in M. pneumoniae was
determined using the Merckoquant peroxide test (Merck,
Darmstadt, Germany) as previously described [10]. Briefly,
growing cells were resuspended in assay buffer and after
incubation for 1 h at 37uC, glucose, glycerol, glycerol-3-phosphate
or glycerophosphodiesters (final concentration 100 mM) were
added to one aliquot. An aliquot without any added carbon
source served as the control. The test strips were dipped into the
suspensions for 1 s and subsequently read.
Preparation and analysis of whole cell extracts
Whole cell extracts of the different M. pneumoniae strains were
prepared as described previously [31]. In order to analyze the
complete proteome, 15 mg of the cell extracts were separated by
one-dimensional 12% SDS-PAGE and the gels subsequently
stained with Coomassie Brillant Blue R250 dye (Serva). For
protein identification, each running lane was cut out into 15 pieces
followed by a separate analysis by mass spectrometry. The
proteome analyses were performed in triplicate.
Gel pieces were washed twice with 200 ml2 0m MN H 4HCO3/
30% (v/v) acetonitrile for 30 min, at 37uC and dried in a vacuum
centrifuge (Concentrator 5301, Eppendorf). Trypsin solution
(10 ng/ml trypsin in 20 mM ammonium bicarbonate) was added
until gel pieces stopped swelling and digestion was allowed to
proceed for 16 to 18 hours at 37uC. Peptides were extracted from
gel pieces by incubation in an ultrasonic bath for 15 min in 20 ml
HPLC grade water and transferred into micro vials for mass
spectrometric analysis.
The tryptic digested proteins obtained from the one-
dimensional SDS PAGE gel pieces were subjected to a reversed
phase column chromatography (Waters BEH 1.7 mm, 100-mm
i.d.6100 mm, Waters Corporation, Milford, Mass., USA) operated
on a nanoACQUITY UPLC (Waters Corporation, Milford, Mass.,
USA). Peptides were first concentrated and desalted on a trapping
column (Waters nanoACQUITY UPLC column, Symmetry C18,
5 mm, 180 mm 6 20 mm, Waters Corporation, Milford, Mass.,
USA) for 3 min at a flow rate of 1 ml/min with 0.1% acetic acid.
Subsequently the peptides were eluted and separated with a non-
linear 80-min gradient from 5–60% acetonitrile in 0.1% acetic acid
at a constant flow rate of 400 nl/min. MS and MS/MS data were
acquired with the LTQ Orbitrap mass spectrometer (Thermo
Fisher, Bremen, Germany) equipped with a nanoelectrospray ion
source. After a survey scan in the Orbitrap (r=30,000), MS/MS
data were recorded for the five most intensive precursor ions in the
linear ion trap. Singly charged ions were not taken into account for
MS/MS analysis.
Tandem mass spectra were extracted using Sorcerer v3.5 (Sage-
N Research). All MS/MS samples were analyzed using
SEQUEST (Thermo Fisher Scientific, San Jose, CA, USA;
version 2.7, revision 11). Database searching was performed
against a target decoy database of M. pneumoniae with added
common laboratory contaminant proteins. Cleavage specificity for
full tryptic cleavage and a maximum of 2 missed cleavages was
assumed. SEQUEST was run with a fragment ion mass tolerance
of 1.00 Da and a parent ion tolerance of 10 ppm. Oxidation of
methionine (+15.99492 Da) and phosphorylation of serine/
threonine/tyrosine (+79.966331 Da) were specified in SEQUEST
as variable modifications. Proteins were identified by at least two
peptides applying a stringent SEQUEST filter (Xcorr vs. charge
state: 1.8 for singly, 2.2 for doubly, 3.3 for triply, and 3.5 for higher
charged ions). To address protein amount differences between the
M. pneumoniae wild type and mutant strains, fold-changes were
calculated by comparing number of assigned spectra for each
protein (mutant vs. wild type strain).
Analysis of mRNA amounts
Preparation of total M. pneumoniae RNA was done as previously
described [29]. For slot blot analysis, serial twofold dilutions of the
RNA extract in 10x SSC (2 mg–0.25 mg) were blotted onto a
positively charged nylon membrane using a PR 648 Slot Blot
Manifold (Amersham Biosciences). Equal amounts of yeast tRNA
(Roche) and M. pneumoniae chromosomal DNA served as controls.
DIG-labelled riboprobes were obtained by in vitro transcription from
PCR products that cover ORF internal sequences using T7 RNA
polymerase (Roche). The reverse primers used to generate the PCR
products contained a T7 promoter sequence (Table S5). The
quantificationwasperformedusingtheImageJsoftwarev1.44c[49].
HeLa cell cytotoxicity assay
Infection of HeLa cell cultures with M. pneumoniae cells was done
as described previously [10,31]. After four days upon infection,
HeLa cells cultures were stained with crystal violet and
photographed. Additionally, lactate dehydrogenase (LDH) release
of HeLa cell cultures after 2 h of infection was used as an index of
cytotoxicity. LDH release was measured with the CytoTox 96
Non-Radioactive Cytotoxicity Assay (Promega) according to the
manufacturer’s instructions. Results are expressed as cytotoxicity
calculated as the percentage of total LDH release after cell lysis
with the lysis buffer provided in the kit. The cytotoxicity assays
were performed in triplicate.
Scanning electron microscopy
After growing of M. pneumoniae cultures in 5 ml volumes to mid-
log, the cells were scraped off and passed ten times through a
syringe. Then, 20 ml of this cell suspension were inoculated to 2 ml
of Hayflick medium in a Lab-Tek chamber slide (Nunc). After
growing cells to mid-log phase, the medium was removed and the
cells were washed three times with PBS and fixed with 1%
glutaraldehyde for 1 h. The samples were washed three times with
PBS and then dehydrated sequentially with 30, 50, 70, 90, and
100% ethanol for 10 min each. Immediately, the critical point
dried of samples was performed (K850 critical point drier;
Emitech Ashfort, United Kingdom) and sputter coated with
20 nm of gold. Samples were observed using a Hitachi S-570
(Tokyo, Japan) scanning electron microscope.
Microcinematography
After passing through a syringe cells grown in a 5 ml culture,
20 ml of disaggregated cells were inoculated to 2 ml of modified
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culture dishes plates (MatTek). Cell movement was examined at
37uC using a Nikon Eclipse TE 2000-E microscope, and images
were captured at intervals of 2 s for a total of 2 min with a digital
sight DS-SMC Nikon camera controlled by NIS-Elements BR
software. Tracks from 50 individual motile cells corresponding to
2 min of observation and 2 separated experiments were analyzed
to determine the gliding velocity and gliding motile patterns.
Supporting Information
Figure S1 Multiple sequence alignment of GlpQ and
MPN566 from M. pneumoniae with orthologous glycer-
ophosphodiesterases of other bacteria. The multiple
sequence alignment was performed using ClustalW (http://www.
ch.embnet.org/software/ClustalW.html) and represented with
BOXSHADE v3.21 (http://www.ch.embnet.org/software/BOX_
form.html). Black shading indicates $80% identity and grey shading
stands for $80% similarity. Amino acids that constitute to the strictly
conserved active site structure are depicted by black arrows. The
UniProtKBentrynamesofthealignedsequencesareY420_MYCPN
(GlpQ, M. pneumoniae), Y566_MYCPN (MPN566, M. pneumoniae),
Y293_MYCGE (MG_293, M. genitalium), Y385_MYCGE (MG_385,
M. genitalium), D4XVJ7_9MOLU (MALL_0582, M. alligatoris),
D4XVF1_9MOLU (MALL_0631, M. alligatoris), Q8XNB7_CLOPE
(GlpQ, Clostridium perfringens), Q8XJ84_CLOPE (GlpQ, C. perfringens),
YHDW_BACSU (YhdW, B. subtilis), GLPQ_BACSU (GlpQ, B.
subtilis), YQIK_BACSU (YqiK, B. subtilis), GLPQ_TREPA (GlpQ,
T. pallidum), GLPQ_HAEIN (GlpQ, H. influenzae), GLPQ_ECOLI
(GlpQ, E. coli), and UGPQ_ECOLI (UgpQ, E. coli).
(TIF)
Figure S2 Scanning electron microscopy analyses of M.
pneumoniae. Morphology and cell division of M. pneumoniae wild
type (wt), glpQ::Tn, and mpn566::Tn mutant strains were compared
with each other. All pictures are shown at the same magnification.
Scale bar, 1.0 mm.
(TIF)
Figure S3 Transcription analysis of interesting genes
with protein amount changes in the glpQ mutant. Slot
blots were performed with whole RNA extracts of M. pneumoniae
wild type (wt), glpQ::Tn, mpn566::Tn, and glpD::Tn (control)
mutant strains grown in modified Hayflick medium containing
either glucose or glycerol as sole carbon source (1% [wt/vol]). A
dilution series of RNA extracts was blotted onto a positively
charged nylon membrane and probed with a DIG-labeled
riboprobe specific for an internal part of a particular open reading
frame. Names of riboprobes are given next to each blot. Signals
obtained with 1 mg of RNA are shown. Yeast tRNA and M.
pneumoniae chromosomal DNA served as controls. Genes which
had a significant higher protein amount in the glpQ::Tn mutant
with glucose as carbon source are shown in (A) and genes with
significant lower protein amounts in (B). For detailed information
on changes of transcript levels see Table S3 and S4.
(TIF)
Table S1 Proteins with differential expression pattern.
List of proteins that are only expressed in the M. pneumoniae wild
type strain when grown in modified Hayflick medium containing
either glucose or glycerol as sole carbon source (1% [wt/vol]).
(DOC)
Table S2 Proteins not detected in proteome analysis.
List of proteins that could not be detected in the MS analysis in all
tested M. pneumoniae strains.
(DOC)
Table S3 Summary of proteome and transcript analysis
in the glpQ mutant GPM81 in the presence of glucose.
Detailed list of significant differences on proteome and transcrip-
tome level in the glpQ mutant GPM81 grown with glucose as sole
carbon source (1% [wt/vol]).
(DOC)
Table S4 Summary of proteome and transcript analysis
in the glpQ mutant GPM81 in the presence of glycerol.
Detailed list of significant differences on proteome and transcrip-
tome level in the glpQ mutant GPM81 grown with glycerol as sole
carbon source (1% [wt/vol]).
(DOC)
Table S5 Oligonucleotides used in this study. List of
oligonucleotides used in this study.
(DOC)
Video S1 Analysis of the gliding velocity and motility
pattern of the M. pneumoniae wild type strain. Examina-
tion of the gliding velocity and motility pattern of the M. pneumoniae
wild type strain over a 2 min period. Tracks from 6 individual cells
are highlighted for better observation.
(MP4)
Video S2 Analysis of the gliding velocity and motility
pattern of the M. pneumoniae glpQ mutant GPM81.
Examination of the gliding velocity and motility pattern of the M.
pneumoniae glpQ mutant GPM81 over a 2 min period. Tracks from
5 individual cells are highlighted for better observation.
(MP4)
Video S3 Analysis of the gliding velocity and motility
pattern of the M. pneumoniae mpn566 mutant GPM82.
Examination of the gliding velocity and motility pattern of the M.
pneumoniae mpn566 mutant GPM82 over a 2 min period. Tracks
from 3 individual cells are highlighted for better observation.
(MP4)
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